Molecular pharmacological studies in the animal model for Alzheimer's disease
阿尔茨海默病动物模型的分子药理学研究
基本信息
- 批准号:13672407
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
β-Amyloid (Aβ) deposited in the senile plaques is thought to be a main cause of Alzheime's disease(AD). According to this AR hypothesis, we tried to develop new animal models of AD. (1) We found that human Tau transgenic mice (R406W) showed behavioral depression at the age of 10 months and SSRI inhibited this behavior. These facts suggested that serotonergic mechanism may play an important role at the early stage of AD. (2) Non-transgenic animal models of AD are also necessary for new drug development. Firstly, we developed a combination treatment of brief cerebral ischemia with intracerebral injection of Aβ1-42 in rats using 8-arm radial maze task. Neither Aβ1-42-treated nor ischemia-subjected rats showed the memory disturbances at the retention test of 7th day. On the other hand, the combination treatment of Aβ1-42 with 10 mm ischemia showed significant disruption of spatial memory Secondary, we combined the ovariectomy (OVX) and intracerebral injection of Aβ1-42 in female rats because of the fact that AD occurs with greater incidence in postmenopausal women. The combination treatment of Aβ1-42 with OVX also slowed significant decrease of serum estrogen and showed memory disturbance in 8-arm radial maze task. Further investigation of these two models indicated that Aβ-induced hippocampal apoptosis and ACh dysfunction may cause the AD's dementia and drugs inhibited these symptoms may be useful for the treatment of AD.
β-淀粉样蛋白(β-Amyloid,Aβ)沉积在老年斑中被认为是阿尔茨海默病(Alzheime 'sdisease,AD)的主要病因之一。根据这一AR假说,我们试图建立新的AD动物模型。(1)我们发现,人Tau转基因小鼠(R406 W)在10月龄时表现出行为抑郁,SSRI抑制了这种行为。这些事实表明,β-肾上腺素能机制可能在AD的早期阶段起重要作用。(2)AD的非转基因动物模型对于新药开发也是必要的。首先,我们采用八臂放射状迷宫实验建立了短暂脑缺血联合脑内注射Aβ1-42的治疗方法。Aβ1-42处理组和缺血组大鼠在第7天的记忆保持试验中均未出现记忆障碍。另一方面,Aβ1-42与10 mm缺血的联合治疗显示空间记忆的显著破坏。其次,我们在雌性大鼠中联合卵巢切除术(OVX)和脑内注射Aβ1-42,因为AD在绝经后女性中的发生率更高。Aβ1-42与OVX联合治疗也可延缓血清雌激素水平的显著下降,并在8臂迷宫中表现出记忆障碍。对这两种模型的进一步研究表明,Aβ诱导的海马细胞凋亡和ACh功能障碍可能导致AD的痴呆,抑制这些症状的药物可能有助于AD的治疗。
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
James J.Palacino, M.Paul Murphy, Ohoshi Murayama, Katsunoii Iwasaki, Michihiro Fujiwara, Akihiko Takashima, Todd E.Golde, Benjamin Wolozin: "Presenilin 1 regulates β-catenin-mediated transcription in a glycogen synthase kinase-3-indipendent fashion"J.Biol
James J.Palacino、M.Paul Murphy、Ohoshi Murayama、Katsunoii Iwasaki、Michihiro Fujiwara、Akihiko Takashima、Todd E.Golde、Benjamin Wolozin:“Presenilin 1 以糖原合成酶激酶 3 独立的方式调节 β-catenin 介导的转录J·比奥尔
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshitaka Tatebayashi et al.: "Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau"Proceeding of National Academy of Sciences. vol.99,21. 13896-13901 (2002)
Yoshitaka Tatebayashi 等人:“表达突变体 (R406W) 人类 tau 的老年小鼠的 Tau 丝形成和联想记忆缺陷”《美国国家科学院院刊》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
James J.Palacino et al.: "Presenilin I regurates β-catenin-mediated transcription in a glycoge synthase kinase-3-indipendent fashion"Journal of Biological Chemistry. 276. 38563-38569 (2001)
James J. Palacino 等人:“Presenilin I 以独立于糖基合酶激酶 3 的方式调节 β-连环蛋白介导的转录”《生物化学杂志》276. 38563-38569 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katsunori Iwasaki et al.: "Ovariectomy combined with β amyloid impairs memory by decreasing acetylcholine release and α7nAChR expression without induction of apoptosis in the hippocampus CA1 neurons of rats"Neurotoxicity Research. 6(in press). (2004)
Katsunori Iwasaki 等人:“卵巢切除术联合 β 淀粉样蛋白通过减少乙酰胆碱释放和 α7nAChR 表达而损害记忆,而不诱导大鼠海马 CA1 神经元细胞凋亡”神经毒性研究 6(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshitaka Tatebayashi, Tomohiro Miyasaka, De-Hua Chui, Takumi Akagi, Kenichi Mishima, Katsunori Iwasaki, Michihiro Fujiwara, Kentaro Tanemura, Miyuki Murayama, Koichi Ishiguro, Emmanuel Planei, Shinji Sato, Tsutomu Hashikawa, amd Akihiko Takashima: "Tau f
馆林喜孝、宫坂智博、崔德华、赤木拓海、三岛健一、岩崎克典、藤原道宏、种村健太郎、村山美雪、石黑浩一、伊曼纽尔·普拉内、佐藤真司、桥川勉、高岛明彦:“Tau f
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWASAKI Katsunori其他文献
IWASAKI Katsunori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWASAKI Katsunori', 18)}}的其他基金
PPARγplays an important role in improvement of cognitive decline in Alzheimer's disease model animals complicated by lifestyle deseases.
PPARγ在改善并发生活方式疾病的阿尔茨海默病模型动物的认知能力下降方面发挥着重要作用。
- 批准号:
21590298 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamics on algebraic varieties and Painleve equations
代数簇动力学和 Painleve 方程
- 批准号:
20340036 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pharmacological studies in accelerating mechanism of Alzheimer's disease by diabetes mellitus with insulin resistance in rats
糖尿病伴胰岛素抵抗加速阿尔茨海默病机制的药理学研究
- 批准号:
19590545 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pharmacological studies in the animal model for Alzheimer' s disease with life-style related disease
生活方式相关疾病阿尔茨海默病动物模型的药理学研究
- 批准号:
17500266 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Geometry and global analysis of Pailneve equations
Pailneve 方程的几何和全局分析
- 批准号:
16340049 - 财政年份:2004
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Differential Equations and Reflection Groups(Polyhedral Harmonics, Hypergeometric Equations, and Painleve Equations)
微分方程和反射群(多面调和、超几何方程和 Painleve 方程)
- 批准号:
12440043 - 财政年份:2000
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on Differential and Difference Equations by Means of Geometric and Algebraic Methods
几何代数方法研究微分方程和差分方程
- 批准号:
09640157 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Mrgprb2 mediated neuroinflammation after cerebral ischemia
Mrgprb2介导脑缺血后的神经炎症
- 批准号:
10644182 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Sexually Dimorphic Amygdala Dysfunction in a Mouse Model of Global Cerebral Ischemia
全脑缺血小鼠模型中的性二形性杏仁核功能障碍
- 批准号:
10828626 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Astrocyte-specific TLR4 signaling and Blood Brain Barrier permeability following acute focal cerebral ischemia
急性局灶性脑缺血后星形胶质细胞特异性 TLR4 信号传导和血脑屏障通透性
- 批准号:
10572987 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
ContinuOuS Monitoring Tool for Delayed Cerebral IsChemia (COSMIC)
迟发性脑缺血持续监测工具 (COSMIC)
- 批准号:
10736589 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Fluoxetine recovery of synaptic dysfunction following juvenile global cerebral ischemia
氟西汀恢复青少年全脑缺血后突触功能障碍
- 批准号:
10509753 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Novel neuroprotective therapy by inhibition of ferroptosis in cerebral ischemia-reperfusion injury
通过抑制脑缺血再灌注损伤中铁死亡的新型神经保护疗法
- 批准号:
22K16676 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Discovery of Plasma Biomarkers of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
蛛网膜下腔出血后迟发性脑缺血血浆生物标志物的发现
- 批准号:
10358411 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Discovery of Plasma Biomarkers of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
蛛网膜下腔出血后迟发性脑缺血血浆生物标志物的发现
- 批准号:
10589874 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Estrous cycle stage at the time of global cerebral ischemia: Implications for hypothalamic-pituitary-gonadal axis function and estrous cycle regularity
全脑缺血时的动情周期阶段:对下丘脑-垂体-性腺轴功能和动情周期规律的影响
- 批准号:
572356-2022 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Innovative Research of Neuroprotection for Delayed Cerebral Ischemia Associated with Cerebral Vasospasm after Subarachnoid Hemorrhage using Novel Hemoglobin-based Oxygen Carrier
新型血红蛋白氧载体对蛛网膜下腔出血后迟发性脑血管痉挛相关迟发性脑缺血的神经保护创新研究
- 批准号:
22K09275 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)